coujoe62 - i agree and would make the same counter
coujoe62 - i agree and would make the same counter argument:
"Jacknjillio I would argue that the company is doing exactly as you state and that is taking care of its obligations to its shareholders."
to again take it further (and i posted this on iLie awhile back several times and it kept being removed) the company is in a unique situation where filing/keeping shareholders current and informed is most likely AGAINST the best interests of those shareholders. the company has a fiduciary responsibility to the shareholders to protect and enhance shareholder value. period. if filing provides an open door for the lenders to convert and dilute with no abandon which would have forced the R/s and then it would have continued - did the company protect its shareholders...? if not filing was the only way to protect them - was it wrong?
now - as far as the suit from the lenders - did they operate in good faith? when they lent the company money and said "we want to be a partner with you" - did that mean immediately destroying the company? in any "normal" lending scenario - do the banks go out and burn your house down while increasing your mortgage payments/amount due every month? one can argue contract law and they signed the contract but contracts are only valid if both parties enter into them in good faith, both parties have a reasonable ability to understand what they are agreeing to, and both parties continue to operate in good faith relative to the contract during its terms. here is where the situation also remains unique - the specific language about the company remaining current in their filings. per the lender agreement - that is a covenant. it allows them the ability to convert/dilute without the company being able to stop them. however, the company's auditor was shut down by the SEC. how many companies did this auditor work with that were connected back to the lender...? that is a different line of questioning.
however, if the company cant reasonably file because of the auditor and the auditor is holding them hostage - are they still operating in good faith? is the lender operating in good faith when holding their feet to the fire? further, where does the obligation to the shareholders begin and end with respect to the contract with the lenders? if honoring that contract means eviscerating the shareholders which is the most basic tenet of being a fiduciary - what is the company to do? further - if the lender is asking them to break that sacred trust (which is what the entire market is predicated upon) - are they really operating in good faith?
whether or not the company offered to pay/settle with cash wont be known until after the trial/filings. but we do know the company had cash coming in and we do know the language Veal used was specific but to what end - we wont know until the company updates.
so - going back to the point about protecting shareholders - it isnt cut and dried with respect to filings. if you originally had 1MM shares at $0.001 and that was then turned into 10K shares at $0.001 due to R/s and ensuing, immediate converting/dilution driving the price right back down - did the company protect you...? there shares have anti dilutive measures built in to maintain control of the company. yours do not.
ultimately - i believe this is what the case will come down to. lender proving damages and it operated in good faith for the entirety of the contract. i think they will be seriously hampered by prior bad acts and the wake of destruction they caused. if HJOE has the cash (which it appears they do based on the last quarter of dealers/product shipments), they should be able to fight back unlike most of the companies that the lenders put under that had not cash resources to mount a defense.
Hangover Joe's Holding Corporation (HJOE) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Hard Knocks for Doximity Investors Alright, so this isn't the place I usually find myself at that hour, but we're living in wild times if you're clinging to Doximity (NYSE:DOCS) shares. Listen up, because those lawyers are chiming in and they ain't just whistling Dixie. If you bought into DOCS between August 2024 and May 2026 and watched your investment bleed red ink,...
Continue Reading
A Shake-Up in Rail Passenger Information Now, here's something from left field that might just have people paying attention while on the go. Teleste, a Finnish company, just put out a gem in rail passenger information systems with the introduction of Acapela's AI-based voice tech into their S-ARRIVE platform. Picture clearer, more natural announcements for every stop,...
Continue Reading
Diving Into the M&A Controversy On the bustling streets of New York, beneath the towering Empire State Building, a plot unfolds that could shake the foundations of your investments—particularly if you're holding shares in Synaptics, Eagle Financial, Victory Capital, or Centerspace. Juan Monteverde and his legal firepower from Monteverde & Associates PC are launching a...
Continue Reading
A Bold Step Towards Integrity Corruption has long been a thorn in the side of progress for many regions, and watching the Hong Kong International Academy Against Corruption (HKIAAC) step up to the plate in Africa feels like a much-needed move. I mean, when you've got the collective wisdom of folks who've been through the wringer on these issues, you'd be wise to pay heed....
Continue Reading
Why Cognizant's Move Matters Imagine being at the top of your game, only to realize you need more heavy-hitters to keep your edge. That’s this deal in a nutshell. Cognizant (NASDAQ: CTSH) is diving deep into AI-led enterprise transformation by scooping up DyFlex Solutions, a name with plenty of clout in the SAP ecosystem. What's Behind the DyFlex Acquisition? Founded in...
Continue Reading
A New Pioneer in AI Business Transformation Who would’ve thought two companies merging into one could shake things up this much? Introducing MOOV—a fresh sprout in the Canadian AI scene that's setting out to redefine how businesses across North America get stuff done. By blending the robust AI chops of Moov AI with the strategic design finesse of Nurun, this firm’s...
Continue Reading
Custom Compounding: A Lifeline for Specific Needs Standard meds can sometimes feel like a one-size-fits-all shirt—sure it fits, but not comfortably for everyone. Enter the world of custom-compounded medications, where pharmacists like Laura Temple in Azle, Texas, create tailor-made solutions for patients. Think of it as fine-tuning the exact gear needed to climb that...
Continue Reading
Pounding the ESG Pavement Every now and then, a story pops up that makes you wonder if the finance folks are finally waking up to what's been slap-you-in-the-face obvious: sustainability ain't just a fancy word for do-gooders anymore. It's the real ticket to the future, and WuXi Biologics (2269.HK) just snagged the top-honor Jade Award at The Asset Corporate...
Continue Reading
Addressing Critical Needs: Hand to Hold's Mission Now, I don't know about you, but when I hear "NICU," my mind goes straight to the intense pressure and emotional rollercoaster that it signifies for families. Hand to Hold, a nonprofit that’s knee-deep in supporting NICU families, isn’t just sitting on their hands. They're hosting a 2026 National NICU Mental Health...
Continue Reading
Highlight Introduces Pulse for Instant Insights Ever find yourself waiting forever for consumer feedback? Well, folks, Highlight's making sure those days are behind us with their new launch: Pulse. They've taken the conventional consumer testing model and flipped it on its head with Highlight Twins. Imagine getting the pulse of your audience in mere seconds, not the...
Continue Reading
Top 5 Most Recently Viewed Articles
Definitive Healthcare Honored as a Premier Workplace Definitive Healthcare (NASDAQ: DH), a leading name in healthcare commercial intelligence, has recently earned prestigious recognition as one of the top employers in Boston. Celebrated by Built In’s 2025 Best Places to Work program, this accolade acknowledges businesses that foster exceptional workplace environments....
Continue Reading
Euroseas Earnings Report: Highlights and Performance The market loves a good surprise, and Euroseas just tossed a nice one into the mix with their latest earnings. Released February 25, 2026, at 08:00 AM, they’ve performed better than expected, snagging attention from investors ready for a ride. Earnings Overview Let’s cut to the chase: Euroseas reported an earnings...
Continue Reading
Introduction to Datroway's Impact on Breast Cancer Treatment AstraZeneca Plc (NASDAQ: AZN) and Daiichi Sankyo have announced remarkable findings from their TROPION-Breast02 Phase 3 trial for the drug Datroway (datopotamab deruxtecan), set to revolutionize the approach to treating triple-negative breast cancer (TNBC). This pharmaceutical collaboration showcases significant...
Continue Reading
Compute Exchange Revolutionizes AI Compute Market Dynamics Today marks a significant shift in the way AI compute resources are bought and sold with the introduction of Compute Exchange. This pioneering platform provides the first open exchange specifically designed for GPUs and various other compute resources, addressing the needs of both buyers and sellers in an...
Continue Reading
NuZee Inc. Makes Headlines with Strategic Relocation NuZee, Inc. NUZE is witnessing a significant surge in its stock trading activity. The reason behind this movement is the recent announcement of the company relocating its U.S. operations from California to Florida. This strategic decision aims to bolster its operational efficiency and accessibility. Global Expansion...
Continue Reading